Pharmaceuticals industry
UK cancels Covid vaccine deal with French firm Valneva
Government serves notice to terminate contract over allegations of a ‘breach of obligations’
Jamie Grierson and Rob Davies
13, Sep, 2021 @12:35 PM
A year that changed the world – and medical companies’ fortunes
While Covid sent many firms to the wall, others prospered by spotting opportunities, from test kits to mask coatings
Julia Kollewe
11, Sep, 2021 @3:00 PM
BioNTech to seek approval for Covid jabs for younger children
Company behind Pfizer vaccine expected to file results of trial of five- to 11-year-olds with regulator soon
Philip Oltermann in Berlin
10, Sep, 2021 @11:35 AM
Pfizer accused of holding Brazil ‘to ransom’ over vaccine contract demands
Leaked supply document reveals clauses to protect US pharma company from legal action in the event of serious side-effects
Mattha Busby and Flávia Milhorance in Rio de Janeiro
10, Sep, 2021 @5:01 AM
Australian Novavax trial participants remain unrecognised by vaccine register
Covid vaccination status of hundreds in limbo because the US company’s jab is yet to be approved in Australia
Christopher Knaus
04, Sep, 2021 @8:00 PM
Japan’s Moderna Covid vaccine rollout hit by recall and contamination scares
Foreign materials including stainless steel identified in batches of Covid-19 vaccine in the country though no safety or efficacy issues reported
Gavin Blair in Tokyo
02, Sep, 2021 @5:20 AM
Major shareholder’s Rolls-Royce grumble could rumble on
Vague demand for board refresh from Causeway likely a hangover from £2bn rights issue
Nils Pratley
31, Aug, 2021 @6:41 PM
Boots launches on-demand delivery trial with Deliveroo
Customers can order medicines for mild ailments, makeup, toiletries and more from 14 stores
Jasper Jolly
23, Aug, 2021 @11:01 PM
Hundreds of UK and EU cosmetics products contain ingredients tested on animals
New analysis finds chemicals tested on animals in moisturisers, lipsticks, hair conditioner and sunscreen, despite ban
Natasha Gilbert and Natalie Grover
19, Aug, 2021 @5:00 AM
Drug firms poised to make billions of dollars from Covid booster jabs
Sales of BioNTech, Moderna and Pfizer drugs could rival $6bn-a-year market for flu vaccines, say analysts
Julia Kollewe
13, Aug, 2021 @4:24 PM
Breast cancer drug approved for NHS after maker agrees discount
Reversal of earlier rejection by Nice of abemaciclib – known as Verzenios – is welcomed by campaigners
Sarah Marsh
12, Aug, 2021 @5:00 AM
Covid-19 vaccines: the contracts, prices and profits
Raised charges and Covax deals on order books of Pfizer, BioNTech, Moderna and AstraZeneca
Julia Kollewe
11, Aug, 2021 @4:58 PM
1 / 179 pages